Bruker
11
43M
10
0.17
1
0.09
- Areas of investment
Summary
Bruker appeared to be the Corporate Investor, which was created in 1960. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Madison.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline GeneFormatics We can highlight the next thriving fund investment areas, such as Biotechnology.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 1
- Rounds per year
- 0.17
- Follow on index
- 0.09
- Investments by industry
- Biotechnology (10)
- Medical (5)
- Health Care (4)
- Medical Device (4)
- Health Diagnostics (3) Show 9 more
- Investments by region
-
- United States (9)
- Switzerland (2)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.82
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Tome Biosciences | 12 Dec 2023 | Biotechnology, Genetics, Medical | Early Stage Venture | 213M | United States, Massachusetts, Watertown |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.